Vera Therapeutics (VERA) Current Leases (2022 - 2025)

Vera Therapeutics (VERA) has 4 years of Current Leases data on file, last reported at $549000.0 in Q4 2025.

• For the quarter ending Q4 2025, Current Leases fell 62.98% year-over-year to $549000.0; the trailing twelve-month figure through Dec 2025 stood at $549000.0 (down 62.98% YoY), and the FY2025 full-year result was $549000.0, down 62.98% from the prior year.
• Current Leases for Q4 2025 stood at $549000.0, up from $473000.0 in the prior quarter.
• Across five years, Current Leases topped out at $2.7 million in Q3 2022 and bottomed at $473000.0 in Q3 2025.
• The 4-year median for Current Leases is $2.4 million (2023), against an average of $2.0 million.
• The widest annual swing landed in 2023, when Current Leases climbed 4.5%; it then slumped 74.73% in 2025.
• A 4-year view of Current Leases shows it stood at $2.6 million in 2022, then decreased by 7.9% to $2.4 million in 2023, then sank by 39.12% to $1.5 million in 2024, then sank by 62.98% to $549000.0 in 2025.
• The last three Current Leases figures came in at $549000.0 (Q4 2025), $473000.0 (Q3 2025), and $855000.0 (Q2 2025), per Business Quant data.

Peer Comparison